(Q42211518)

English

Emergence of resistant variants detected by ultra-deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1.

scientific article published on 19 June 2014

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943406%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Emergence of resistant variants detected by ultra-deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943406%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

K Kosaka

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943406%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

M Imamura

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943406%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

H Abe

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943406%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

N Hiraga

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943406%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

S Yoshimi

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943406%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

E Murakami

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943406%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

T Kawaoka

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943406%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

M Tsuge

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943406%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

H Aikata

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943406%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

H Ochi

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943406%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

H Matsui

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943406%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

A Kanai

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943406%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

T Inaba

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943406%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

K Chayama

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943406%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

19 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943406%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943406%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943406%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943406%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

158-165

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943406%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Telaprevir for retreatment of HCV infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Telaprevir for previously untreated chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Efficacy and safety of telaprevir, a new protease inhibitor, for difficult-to-treat patients with genotype 1 chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032).

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Genetic heterogeneity of hepatitis C virus in association with antiviral therapy determined by ultra-deep sequencing

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Use of illumina deep sequencing technology to differentiate hepatitis C virus variants

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Analysis of hepatitis C virus intrahost diversity across the coding region by ultradeep pyrosequencing

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Emergence of telaprevir-resistant variants detected by ultra-deep sequencing after triple therapy in patients infected with HCV genotype 1.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Randomized trial of high-dose interferon-alpha-2b combined with ribavirin in patients with chronic hepatitis C: Correlation between amino acid substitutions in the core/NS5A region and virological response to interferon therapy

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Fast and accurate short read alignment with Burrows-Wheeler transform

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Evolution of Resistant M414T Mutants among Hepatitis C Virus Replicon Cells Treated with Polymerase Inhibitor A-782759

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevir

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12271

21 January 2018

Identifiers

10.1111/JVH.12271

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943406%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943406%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42211518&oldid=1760237208"